Get the Stockscreener App
6.80
0.07%
0.005
Evolus Inc stock is traded at $6.80, with a volume of 11,902.
It is up +0.07% in the last 24 hours and down -0.15% over the past month.
Evolus Inc is a performance beauty company with a customer-centric approach to delivering breakthrough products in the self-pay aesthetic market. The company's first commercial product is Jeuveau, a proprietary 900 kilodalton, purified botulinum toxin type A formulation indicated for the temporary improvement in the appearance of moderate to severe glabellar lines, also known as frown lines, in adults. Its primary market is the cash-pay aesthetic market, which includes medical products purchased by physicians and other customers that are then sold to consumers or used in procedures for aesthetic indications. It generates product revenue from the sale of Jeuveau in the United States and Europe, and service revenue from distribution partners in Canada.
See More
Previous Close:
$6.795
Open:
$6.85
24h Volume:
11,902
Relative Volume:
0.01
Market Cap:
$441.42M
Revenue:
$202.09M
Net Income/Loss:
$-61.69M
P/E Ratio:
-6.2963
EPS:
-1.08
Net Cash Flow:
$-35.64M
1W Performance:
-5.03%
1M Performance:
-0.15%
6M Performance:
-30.18%
1Y Performance:
-46.41%
1-Day Range:
$6.78
$6.86
1-Week Range:
$6.355
$7.1499
52-Week Range:
$5.71
$17.12
Evolus Inc Stock (EOLS) Company Profile
Name
Evolus Inc
Sector
Phone
(949) 284-4555
Address
520 NEWPORT CENTER DRIVE, NEWPORT BEACH
Compare EOLS with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
EOLS
Evolus Inc
|
6.81 | 441.42M | 202.09M | -61.69M | -35.64M | -1.08 |
|
ZTS
Zoetis Inc
|
120.38 | 53.06B | 9.40B | 2.65B | 2.24B | 5.935 |
|
TAK
Takeda Pharmaceutical Co Adr
|
14.24 | 45.11B | 29.63B | 260.53M | 5.51B | 0.0788 |
|
HLN
Haleon Plc Adr
|
9.595 | 42.44B | 14.26B | 1.98B | 2.47B | 0.4327 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
28.50 | 32.59B | 16.70B | -157.13M | 1.19B | -0.1446 |
|
UTHR
United Therapeutics Corp
|
482.51 | 20.84B | 3.08B | 1.24B | 1.07B | 25.61 |
Evolus Inc Stock (EOLS) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Aug-06-25 | Downgrade | Needham | Buy → Hold |
| Apr-17-25 | Initiated | BTIG Research | Buy |
| Jan-29-24 | Upgrade | Barclays | Equal Weight → Overweight |
| Jun-23-22 | Initiated | Needham | Buy |
| May-12-22 | Upgrade | Barclays | Underweight → Equal Weight |
| Jan-20-22 | Upgrade | Truist | Hold → Buy |
| May-06-21 | Upgrade | Mizuho | Neutral → Buy |
| Apr-08-21 | Reiterated | H.C. Wainwright | Buy |
| Feb-24-21 | Downgrade | Truist | Buy → Hold |
| Jul-07-20 | Downgrade | Mizuho | Buy → Neutral |
| Feb-06-20 | Resumed | Mizuho | Buy |
| Nov-26-19 | Initiated | SVB Leerink | Outperform |
| Sep-05-19 | Resumed | Mizuho | Buy |
| Jun-28-19 | Initiated | Wells Fargo | Market Perform |
| Jun-11-19 | Initiated | Barclays | Underweight |
| Mar-20-19 | Initiated | SunTrust | Buy |
| Feb-14-19 | Initiated | H.C. Wainwright | Buy |
| Jan-29-19 | Initiated | Stifel | Buy |
View All
Evolus Inc Stock (EOLS) Latest News
Stonepine Capital Management LLC Has $8.44 Million Holdings in Evolus, Inc. $EOLS - MarketBeat
How Evolus Inc. (EVL) stock compares with tech leadersWeekly Earnings Recap & Technical Entry and Exit Alerts - Newser
Why Evolus Inc. stock attracts global investorsJuly 2025 Volume & Community Consensus Picks - Newser
Mizuho lowers Evolus stock price target on consumer sentiment concerns By Investing.com - Investing.com Nigeria
Mizuho lowers Evolus stock price target on consumer sentiment concerns - Investing.com India
Midday Stock Roundup: Tilly’s, indie Semiconductor Up - Orange County Business Journal
Is Evolus Inc. stock a defensive play in 2025July 2025 Recap & Technical Pattern Based Buy Signals - Newser
How Evolus Inc. (EVL) stock behaves in tightening cyclesJuly 2025 Closing Moves & Stepwise Entry and Exit Trade Signals - Newser
How cyclical is Evolus Inc. (EVL) stock compared to rivalsEarnings Beat & Free Low Drawdown Momentum Trade Ideas - Newser
How Evolus Inc. (EVL) stock reacts to stronger dollarQuarterly Market Review & Verified Entry Point Signals - Newser
Will Evolus Inc. (EVL) stock beat Nasdaq index returnsEarnings Growth Summary & Accurate Entry/Exit Alerts - Newser
Mizuho Maintains Evolus (EOLS) Outperform Recommendation - Nasdaq
H.C. Wainwright reiterates Buy rating on Evolus stock with $20 price target - Investing.com Nigeria
Analyst Mizuho Lowers Price Target for Evolus (EOLS) to $19.00 | - GuruFocus
Evolus price target lowered to $19 from $20 at Mizuho - TipRanks
Is Evolus Inc. (EVL) stock a fit for income portfoliosJuly 2025 WrapUp & AI Enhanced Trading Alerts - Newser
How Evolus Inc. (EVL) stock expands through international marketsShort Setup & Advanced Technical Analysis Signals - Newser
Mizuho lowers Evolus stock price target to $19 on consumer sentiment concerns - Investing.com Canada
Can Evolus Inc. stock deliver strong Q4 earningsMarket Growth Review & Daily Stock Momentum Reports - BỘ NỘI VỤ
Price-Driven Insight from (EOLS) for Rule-Based Strategy - news.stocktradersdaily.com
Evolus, Inc.'s (NASDAQ:EOLS) Path To Profitability - Yahoo Finance
Midday Stock Roundup: LoanDepot Falls After Top Executive Sells Shares - Orange County Business Journal
Will Evolus Inc. (EVL) stock announce a stock split2025 Top Gainers & Free Technical Pattern Based Buy Signals - newser.com
Is Evolus Inc. (EVL) stock considered safe havenJuly 2025 Update & Short-Term Swing Trade Alerts - newser.com
Will Evolus Inc. stock see insider buyingJuly 2025 Intraday Action & Free Fast Gain Swing Trade Alerts - newser.com
Is Evolus Inc. stock trading near support levels2025 Breakouts & Breakdowns & Weekly Market Pulse Updates - newser.com
Short interest data insights for Evolus Inc.July 2025 Highlights & Free Real-Time Market Sentiment Alerts - newser.com
Can momentum traders help lift Evolus Inc.Quarterly Risk Review & Free Real-Time Market Sentiment Alerts - newser.com
What margin trends mean for Evolus Inc. stockMarket Trend Summary & Smart Allocation Stock Tips - newser.com
Evolus Inc Stock (EOLS) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.50%
0.77%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):